世界のカルチノイド症候群下痢治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Carcinoid Syndrome Diarrhea Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1107 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、カルチノイド症候群下痢治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、ソマトスタチンアナログ（SSA）療法、経口療法）、用途別市場規模（病院、クリニック、がん研究所）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・カルチノイド症候群下痢治療の市場動向 ・企業の競争状況、市場シェア ・カルチノイド症候群下痢治療の種類別市場規模（化学療法、ソマトスタチンアナログ（SSA）療法、経口療法） ・カルチノイド症候群下痢治療の用途別市場規模（病院、クリニック、がん研究所） ・カルチノイド症候群下痢治療の北米市場規模2016-2027（アメリカ、カナダ） ・カルチノイド症候群下痢治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・カルチノイド症候群下痢治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・カルチノイド症候群下痢治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・カルチノイド症候群下痢治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Lexicon Pharmaceuticals、Novartis International、Pharmascience、Omega Laboratories、Teva Pharmaceutical Industries、Mylan、Ipsen、Sirtex Medical、BTG International） ・結論

Carcinoid syndrome is a group of symptoms that can occur in patients suffering from carcinoid tumors which also called as metastatic neuroendocrine tumors. Carcinoid tumors are rare and these are slow growing tumors. Most of the tumors occur in gastrointestinal tract. According to FDA, carcinoid syndrome occurs in less than 10 percent of people suffering from carcinoid tumors, mostly after the tumor has spread to the liver. This syndrome causes overproduction of serotonin hormone which results in chronic diarrhea. Chronic diarrhea leads to malnutrition, weight loss, electrolyte imbalance and dehydration.
Carcinoid syndrome diarrhea is a rare condition. Treatment available for this condition are expected to get orphan drug status. Government and regulatory body support for development of orphan drug and incentives are expected to drive carcinoid syndrome treatment market. Government allow companies to set high price for the orphan drug and which in turn will generate high revenue. Ineffectiveness of diarrhea controlling agents in case of carcinoid syndromes diarrhea will also drive the growth of this market.

Market Analysis and Insights: Global Carcinoid Syndrome Diarrhea Treatment Market
The global Carcinoid Syndrome Diarrhea Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Carcinoid Syndrome Diarrhea Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Carcinoid Syndrome Diarrhea Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Carcinoid Syndrome Diarrhea Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Carcinoid Syndrome Diarrhea Treatment market.

Global Carcinoid Syndrome Diarrhea Treatment Scope and Market Size
Carcinoid Syndrome Diarrhea Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Carcinoid Syndrome Diarrhea Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Chemotherapy
Somatostatin Analog (SSA) Therapy
Oral Therapy

Segment by Application
Hospitals
Clinics
Cancer Research Institutes

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Lexicon Pharmaceuticals
Novartis International
Pharmascience
Omega Laboratories
Teva Pharmaceutical Industries
Mylan
Ipsen
Sirtex Medical
BTG International

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Carcinoid Syndrome Diarrhea Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy
1.2.3 Somatostatin Analog (SSA) Therapy
1.2.4 Oral Therapy
1.3 Market by Application
1.3.1 Global Carcinoid Syndrome Diarrhea Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Cancer Research Institutes
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Carcinoid Syndrome Diarrhea Treatment Market Perspective (2016-2027)
2.2 Carcinoid Syndrome Diarrhea Treatment Growth Trends by Regions
2.2.1 Carcinoid Syndrome Diarrhea Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Carcinoid Syndrome Diarrhea Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Carcinoid Syndrome Diarrhea Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Carcinoid Syndrome Diarrhea Treatment Industry Dynamic
2.3.1 Carcinoid Syndrome Diarrhea Treatment Market Trends
2.3.2 Carcinoid Syndrome Diarrhea Treatment Market Drivers
2.3.3 Carcinoid Syndrome Diarrhea Treatment Market Challenges
2.3.4 Carcinoid Syndrome Diarrhea Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Carcinoid Syndrome Diarrhea Treatment Players by Revenue
3.1.1 Global Top Carcinoid Syndrome Diarrhea Treatment Players by Revenue (2016-2021)
3.1.2 Global Carcinoid Syndrome Diarrhea Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Carcinoid Syndrome Diarrhea Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Carcinoid Syndrome Diarrhea Treatment Revenue
3.4 Global Carcinoid Syndrome Diarrhea Treatment Market Concentration Ratio
3.4.1 Global Carcinoid Syndrome Diarrhea Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Carcinoid Syndrome Diarrhea Treatment Revenue in 2020
3.5 Carcinoid Syndrome Diarrhea Treatment Key Players Head office and Area Served
3.6 Key Players Carcinoid Syndrome Diarrhea Treatment Product Solution and Service
3.7 Date of Enter into Carcinoid Syndrome Diarrhea Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Carcinoid Syndrome Diarrhea Treatment Breakdown Data by Type
4.1 Global Carcinoid Syndrome Diarrhea Treatment Historic Market Size by Type (2016-2021)
4.2 Global Carcinoid Syndrome Diarrhea Treatment Forecasted Market Size by Type (2022-2027)

5 Carcinoid Syndrome Diarrhea Treatment Breakdown Data by Application
5.1 Global Carcinoid Syndrome Diarrhea Treatment Historic Market Size by Application (2016-2021)
5.2 Global Carcinoid Syndrome Diarrhea Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Carcinoid Syndrome Diarrhea Treatment Market Size (2016-2027)
6.2 North America Carcinoid Syndrome Diarrhea Treatment Market Size by Type
6.2.1 North America Carcinoid Syndrome Diarrhea Treatment Market Size by Type (2016-2021)
6.2.2 North America Carcinoid Syndrome Diarrhea Treatment Market Size by Type (2022-2027)
6.2.3 North America Carcinoid Syndrome Diarrhea Treatment Market Size by Type (2016-2027)
6.3 North America Carcinoid Syndrome Diarrhea Treatment Market Size by Application
6.3.1 North America Carcinoid Syndrome Diarrhea Treatment Market Size by Application (2016-2021)
6.3.2 North America Carcinoid Syndrome Diarrhea Treatment Market Size by Application (2022-2027)
6.3.3 North America Carcinoid Syndrome Diarrhea Treatment Market Size by Application (2016-2027)
6.4 North America Carcinoid Syndrome Diarrhea Treatment Market Size by Country
6.4.1 North America Carcinoid Syndrome Diarrhea Treatment Market Size by Country (2016-2021)
6.4.2 North America Carcinoid Syndrome Diarrhea Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Carcinoid Syndrome Diarrhea Treatment Market Size (2016-2027)
7.2 Europe Carcinoid Syndrome Diarrhea Treatment Market Size by Type
7.2.1 Europe Carcinoid Syndrome Diarrhea Treatment Market Size by Type (2016-2021)
7.2.2 Europe Carcinoid Syndrome Diarrhea Treatment Market Size by Type (2022-2027)
7.2.3 Europe Carcinoid Syndrome Diarrhea Treatment Market Size by Type (2016-2027)
7.3 Europe Carcinoid Syndrome Diarrhea Treatment Market Size by Application
7.3.1 Europe Carcinoid Syndrome Diarrhea Treatment Market Size by Application (2016-2021)
7.3.2 Europe Carcinoid Syndrome Diarrhea Treatment Market Size by Application (2022-2027)
7.3.3 Europe Carcinoid Syndrome Diarrhea Treatment Market Size by Application (2016-2027)
7.4 Europe Carcinoid Syndrome Diarrhea Treatment Market Size by Country
7.4.1 Europe Carcinoid Syndrome Diarrhea Treatment Market Size by Country (2016-2021)
7.4.2 Europe Carcinoid Syndrome Diarrhea Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Carcinoid Syndrome Diarrhea Treatment Market Size (2016-2027)
8.2 Asia-Pacific Carcinoid Syndrome Diarrhea Treatment Market Size by Type
8.2.1 Asia-Pacific Carcinoid Syndrome Diarrhea Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Carcinoid Syndrome Diarrhea Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Carcinoid Syndrome Diarrhea Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Carcinoid Syndrome Diarrhea Treatment Market Size by Application
8.3.1 Asia-Pacific Carcinoid Syndrome Diarrhea Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Carcinoid Syndrome Diarrhea Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Carcinoid Syndrome Diarrhea Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Carcinoid Syndrome Diarrhea Treatment Market Size by Region
8.4.1 Asia-Pacific Carcinoid Syndrome Diarrhea Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Carcinoid Syndrome Diarrhea Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Carcinoid Syndrome Diarrhea Treatment Market Size (2016-2027)
9.2 Latin America Carcinoid Syndrome Diarrhea Treatment Market Size by Type
9.2.1 Latin America Carcinoid Syndrome Diarrhea Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Carcinoid Syndrome Diarrhea Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Carcinoid Syndrome Diarrhea Treatment Market Size by Type (2016-2027)
9.3 Latin America Carcinoid Syndrome Diarrhea Treatment Market Size by Application
9.3.1 Latin America Carcinoid Syndrome Diarrhea Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Carcinoid Syndrome Diarrhea Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Carcinoid Syndrome Diarrhea Treatment Market Size by Application (2016-2027)
9.4 Latin America Carcinoid Syndrome Diarrhea Treatment Market Size by Country
9.4.1 Latin America Carcinoid Syndrome Diarrhea Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Carcinoid Syndrome Diarrhea Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Carcinoid Syndrome Diarrhea Treatment Market Size (2016-2027)
10.2 Middle East & Africa Carcinoid Syndrome Diarrhea Treatment Market Size by Type
10.2.1 Middle East & Africa Carcinoid Syndrome Diarrhea Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Carcinoid Syndrome Diarrhea Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Carcinoid Syndrome Diarrhea Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Carcinoid Syndrome Diarrhea Treatment Market Size by Application
10.3.1 Middle East & Africa Carcinoid Syndrome Diarrhea Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Carcinoid Syndrome Diarrhea Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Carcinoid Syndrome Diarrhea Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Carcinoid Syndrome Diarrhea Treatment Market Size by Country
10.4.1 Middle East & Africa Carcinoid Syndrome Diarrhea Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Carcinoid Syndrome Diarrhea Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Lexicon Pharmaceuticals
11.1.1 Lexicon Pharmaceuticals Company Details
11.1.2 Lexicon Pharmaceuticals Business Overview
11.1.3 Lexicon Pharmaceuticals Carcinoid Syndrome Diarrhea Treatment Introduction
11.1.4 Lexicon Pharmaceuticals Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2016-2021)
11.1.5 Lexicon Pharmaceuticals Recent Development
11.2 Novartis International
11.2.1 Novartis International Company Details
11.2.2 Novartis International Business Overview
11.2.3 Novartis International Carcinoid Syndrome Diarrhea Treatment Introduction
11.2.4 Novartis International Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2016-2021)
11.2.5 Novartis International Recent Development
11.3 Pharmascience
11.3.1 Pharmascience Company Details
11.3.2 Pharmascience Business Overview
11.3.3 Pharmascience Carcinoid Syndrome Diarrhea Treatment Introduction
11.3.4 Pharmascience Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2016-2021)
11.3.5 Pharmascience Recent Development
11.4 Omega Laboratories
11.4.1 Omega Laboratories Company Details
11.4.2 Omega Laboratories Business Overview
11.4.3 Omega Laboratories Carcinoid Syndrome Diarrhea Treatment Introduction
11.4.4 Omega Laboratories Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2016-2021)
11.4.5 Omega Laboratories Recent Development
11.5 Teva Pharmaceutical Industries
11.5.1 Teva Pharmaceutical Industries Company Details
11.5.2 Teva Pharmaceutical Industries Business Overview
11.5.3 Teva Pharmaceutical Industries Carcinoid Syndrome Diarrhea Treatment Introduction
11.5.4 Teva Pharmaceutical Industries Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2016-2021)
11.5.5 Teva Pharmaceutical Industries Recent Development
11.6 Mylan
11.6.1 Mylan Company Details
11.6.2 Mylan Business Overview
11.6.3 Mylan Carcinoid Syndrome Diarrhea Treatment Introduction
11.6.4 Mylan Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2016-2021)
11.6.5 Mylan Recent Development
11.7 Ipsen
11.7.1 Ipsen Company Details
11.7.2 Ipsen Business Overview
11.7.3 Ipsen Carcinoid Syndrome Diarrhea Treatment Introduction
11.7.4 Ipsen Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2016-2021)
11.7.5 Ipsen Recent Development
11.8 Sirtex Medical
11.8.1 Sirtex Medical Company Details
11.8.2 Sirtex Medical Business Overview
11.8.3 Sirtex Medical Carcinoid Syndrome Diarrhea Treatment Introduction
11.8.4 Sirtex Medical Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2016-2021)
11.8.5 Sirtex Medical Recent Development
11.9 BTG International
11.9.1 BTG International Company Details
11.9.2 BTG International Business Overview
11.9.3 BTG International Carcinoid Syndrome Diarrhea Treatment Introduction
11.9.4 BTG International Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2016-2021)
11.9.5 BTG International Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Carcinoid Syndrome Diarrhea Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Somatostatin Analog (SSA) Therapy
Table 4. Key Players of Oral Therapy
Table 5. Global Carcinoid Syndrome Diarrhea Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Carcinoid Syndrome Diarrhea Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Carcinoid Syndrome Diarrhea Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Carcinoid Syndrome Diarrhea Treatment Market Share by Regions (2016-2021)
Table 9. Global Carcinoid Syndrome Diarrhea Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Carcinoid Syndrome Diarrhea Treatment Market Share by Regions (2022-2027)
Table 11. Carcinoid Syndrome Diarrhea Treatment Market Trends
Table 12. Carcinoid Syndrome Diarrhea Treatment Market Drivers
Table 13. Carcinoid Syndrome Diarrhea Treatment Market Challenges
Table 14. Carcinoid Syndrome Diarrhea Treatment Market Restraints
Table 15. Global Carcinoid Syndrome Diarrhea Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Carcinoid Syndrome Diarrhea Treatment Market Share by Players (2016-2021)
Table 17. Global Top Carcinoid Syndrome Diarrhea Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Carcinoid Syndrome Diarrhea Treatment as of 2020)
Table 18. Ranking of Global Top Carcinoid Syndrome Diarrhea Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Carcinoid Syndrome Diarrhea Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Carcinoid Syndrome Diarrhea Treatment Product Solution and Service
Table 22. Date of Enter into Carcinoid Syndrome Diarrhea Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Carcinoid Syndrome Diarrhea Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Carcinoid Syndrome Diarrhea Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Carcinoid Syndrome Diarrhea Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Carcinoid Syndrome Diarrhea Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Carcinoid Syndrome Diarrhea Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Carcinoid Syndrome Diarrhea Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Carcinoid Syndrome Diarrhea Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Carcinoid Syndrome Diarrhea Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Carcinoid Syndrome Diarrhea Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Carcinoid Syndrome Diarrhea Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Carcinoid Syndrome Diarrhea Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Carcinoid Syndrome Diarrhea Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Carcinoid Syndrome Diarrhea Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Carcinoid Syndrome Diarrhea Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Carcinoid Syndrome Diarrhea Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Carcinoid Syndrome Diarrhea Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Carcinoid Syndrome Diarrhea Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Carcinoid Syndrome Diarrhea Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Carcinoid Syndrome Diarrhea Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Carcinoid Syndrome Diarrhea Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Carcinoid Syndrome Diarrhea Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Carcinoid Syndrome Diarrhea Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Carcinoid Syndrome Diarrhea Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Carcinoid Syndrome Diarrhea Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Carcinoid Syndrome Diarrhea Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Carcinoid Syndrome Diarrhea Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Carcinoid Syndrome Diarrhea Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Carcinoid Syndrome Diarrhea Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Carcinoid Syndrome Diarrhea Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Carcinoid Syndrome Diarrhea Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Carcinoid Syndrome Diarrhea Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Carcinoid Syndrome Diarrhea Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Carcinoid Syndrome Diarrhea Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Carcinoid Syndrome Diarrhea Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Carcinoid Syndrome Diarrhea Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Carcinoid Syndrome Diarrhea Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Carcinoid Syndrome Diarrhea Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Carcinoid Syndrome Diarrhea Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Lexicon Pharmaceuticals Company Details
Table 63. Lexicon Pharmaceuticals Business Overview
Table 64. Lexicon Pharmaceuticals Carcinoid Syndrome Diarrhea Treatment Product
Table 65. Lexicon Pharmaceuticals Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2016-2021) & (US$ Million)
Table 66. Lexicon Pharmaceuticals Recent Development
Table 67. Novartis International Company Details
Table 68. Novartis International Business Overview
Table 69. Novartis International Carcinoid Syndrome Diarrhea Treatment Product
Table 70. Novartis International Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2016-2021) & (US$ Million)
Table 71. Novartis International Recent Development
Table 72. Pharmascience Company Details
Table 73. Pharmascience Business Overview
Table 74. Pharmascience Carcinoid Syndrome Diarrhea Treatment Product
Table 75. Pharmascience Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2016-2021) & (US$ Million)
Table 76. Pharmascience Recent Development
Table 77. Omega Laboratories Company Details
Table 78. Omega Laboratories Business Overview
Table 79. Omega Laboratories Carcinoid Syndrome Diarrhea Treatment Product
Table 80. Omega Laboratories Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2016-2021) & (US$ Million)
Table 81. Omega Laboratories Recent Development
Table 82. Teva Pharmaceutical Industries Company Details
Table 83. Teva Pharmaceutical Industries Business Overview
Table 84. Teva Pharmaceutical Industries Carcinoid Syndrome Diarrhea Treatment Product
Table 85. Teva Pharmaceutical Industries Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2016-2021) & (US$ Million)
Table 86. Teva Pharmaceutical Industries Recent Development
Table 87. Mylan Company Details
Table 88. Mylan Business Overview
Table 89. Mylan Carcinoid Syndrome Diarrhea Treatment Product
Table 90. Mylan Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2016-2021) & (US$ Million)
Table 91. Mylan Recent Development
Table 92. Ipsen Company Details
Table 93. Ipsen Business Overview
Table 94. Ipsen Carcinoid Syndrome Diarrhea Treatment Product
Table 95. Ipsen Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2016-2021) & (US$ Million)
Table 96. Ipsen Recent Development
Table 97. Sirtex Medical Company Details
Table 98. Sirtex Medical Business Overview
Table 99. Sirtex Medical Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2016-2021) & (US$ Million)
Table 100. Sirtex Medical Recent Development
Table 101. BTG International Company Details
Table 102. BTG International Business Overview
Table 103. BTG International Carcinoid Syndrome Diarrhea Treatment Product
Table 104. BTG International Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2016-2021) & (US$ Million)
Table 105. BTG International Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Carcinoid Syndrome Diarrhea Treatment Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapy Features
Figure 3. Somatostatin Analog (SSA) Therapy Features
Figure 4. Oral Therapy Features
Figure 5. Global Carcinoid Syndrome Diarrhea Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Cancer Research Institutes Case Studies
Figure 9. Carcinoid Syndrome Diarrhea Treatment Report Years Considered
Figure 10. Global Carcinoid Syndrome Diarrhea Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Carcinoid Syndrome Diarrhea Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Carcinoid Syndrome Diarrhea Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Carcinoid Syndrome Diarrhea Treatment Market Share by Regions (2022-2027)
Figure 14. Global Carcinoid Syndrome Diarrhea Treatment Market Share by Players in 2020
Figure 15. Global Top Carcinoid Syndrome Diarrhea Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Carcinoid Syndrome Diarrhea Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Carcinoid Syndrome Diarrhea Treatment Revenue in 2020
Figure 17. Global Carcinoid Syndrome Diarrhea Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Carcinoid Syndrome Diarrhea Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Carcinoid Syndrome Diarrhea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Carcinoid Syndrome Diarrhea Treatment Market Share by Type (2016-2027)
Figure 21. North America Carcinoid Syndrome Diarrhea Treatment Market Share by Application (2016-2027)
Figure 22. North America Carcinoid Syndrome Diarrhea Treatment Market Share by Country (2016-2027)
Figure 23. United States Carcinoid Syndrome Diarrhea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Carcinoid Syndrome Diarrhea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Carcinoid Syndrome Diarrhea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Carcinoid Syndrome Diarrhea Treatment Market Share by Type (2016-2027)
Figure 27. Europe Carcinoid Syndrome Diarrhea Treatment Market Share by Application (2016-2027)
Figure 28. Europe Carcinoid Syndrome Diarrhea Treatment Market Share by Country (2016-2027)
Figure 29. Germany Carcinoid Syndrome Diarrhea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Carcinoid Syndrome Diarrhea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Carcinoid Syndrome Diarrhea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Carcinoid Syndrome Diarrhea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Carcinoid Syndrome Diarrhea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Carcinoid Syndrome Diarrhea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Carcinoid Syndrome Diarrhea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Carcinoid Syndrome Diarrhea Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Carcinoid Syndrome Diarrhea Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Carcinoid Syndrome Diarrhea Treatment Market Share by Region (2016-2027)
Figure 39. China Carcinoid Syndrome Diarrhea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Carcinoid Syndrome Diarrhea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Carcinoid Syndrome Diarrhea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Carcinoid Syndrome Diarrhea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Carcinoid Syndrome Diarrhea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Carcinoid Syndrome Diarrhea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Carcinoid Syndrome Diarrhea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Carcinoid Syndrome Diarrhea Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Carcinoid Syndrome Diarrhea Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Carcinoid Syndrome Diarrhea Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Carcinoid Syndrome Diarrhea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Carcinoid Syndrome Diarrhea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Carcinoid Syndrome Diarrhea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Carcinoid Syndrome Diarrhea Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Carcinoid Syndrome Diarrhea Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Carcinoid Syndrome Diarrhea Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Carcinoid Syndrome Diarrhea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Carcinoid Syndrome Diarrhea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Carcinoid Syndrome Diarrhea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Lexicon Pharmaceuticals Revenue Growth Rate in Carcinoid Syndrome Diarrhea Treatment Business (2016-2021)
Figure 59. Novartis International Revenue Growth Rate in Carcinoid Syndrome Diarrhea Treatment Business (2016-2021)
Figure 60. Pharmascience Revenue Growth Rate in Carcinoid Syndrome Diarrhea Treatment Business (2016-2021)
Figure 61. Omega Laboratories Revenue Growth Rate in Carcinoid Syndrome Diarrhea Treatment Business (2016-2021)
Figure 62. Teva Pharmaceutical Industries Revenue Growth Rate in Carcinoid Syndrome Diarrhea Treatment Business (2016-2021)
Figure 63. Mylan Revenue Growth Rate in Carcinoid Syndrome Diarrhea Treatment Business (2016-2021)
Figure 64. Ipsen Revenue Growth Rate in Carcinoid Syndrome Diarrhea Treatment Business (2016-2021)
Figure 65. Sirtex Medical Revenue Growth Rate in Carcinoid Syndrome Diarrhea Treatment Business (2016-2021)
Figure 66. BTG International Revenue Growth Rate in Carcinoid Syndrome Diarrhea Treatment Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

---